Disease modeling using human induced pluripotent stem cells: lessons from the liver

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Genetics

Background:

• Human pluripotent stem cells (hPSCs) possess the unique ability to differentiate into all human cell types.
• hPSCs are crucial for regenerative medicine, disease modeling, and drug screening.
• Human induced pluripotent stem cells (hIPSCs) offer patient-specific disease modeling and drug screening platforms.

Purpose of the Study:

• To review the evolution of human pluripotent stem cell technology.
• To highlight the applications of hPSCs and hIPSCs in disease modeling and drug screening.
• To provide examples of inherited metabolic liver disorders modeled using hIPSCs.

Main Methods:

• Review of scientific literature on hPSC and hIPSC isolation and optimization.
• Discussion of hIPSC applications in disease modeling for monogenic and complex diseases.
• Case studies of inherited metabolic liver disorders modeled using hIPSCs.

Main Results:

• hPSCs have advanced regenerative medicine and human development studies.
• hIPSCs have made disease modeling more accessible and physiologically relevant.
• hIPSC-derived models are effective for studying monogenic diseases and for phenotype-based drug screening.

Conclusions:

• hPSCs and hIPSCs represent significant advancements in biomedical research.
• These stem cell technologies are transforming our understanding and treatment of diseases.
• The application of hIPSCs in modeling inherited metabolic liver disorders demonstrates their clinical potential.